Editas Medicine, Inc.

Biotechnology company · Cambridge, Massachusetts, United States · Nasdaq: EDIT

Editas Medicine, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker EDIT. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $225,000 in total, most recently in 2015. It has reported private securities offerings to the US SEC, most recently $120 million sold in a notice filed in 2015.

editasmedicine.comProfile compiled from public records. Is this your company? Request a correction or update

Editas Medicine at a glance

Typebiotechnology company
HeadquartersCambridge, Massachusetts, United States
Earliest incorporation on record2013
Stock listingNasdaq: EDIT
SEC industryBiological Products, (No Diagnostic Substances)
Employees (per SBIR records)14
SEC CIK1650664

What does Editas Medicine do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $225,000 in total (2015).

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $120 million sold (2015).

Frequently asked questions about Editas Medicine

Where is Editas Medicine headquartered?

Editas Medicine, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Editas Medicine do?

Editas Medicine, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Editas Medicine a public company?

Yes. Editas Medicine, Inc. trades on Nasdaq under the ticker EDIT.

When was Editas Medicine founded?

The earliest incorporation on record for Editas Medicine, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.